The Latest: China donates vaccine doses to UN peacekeepers
The Associated Press
FacebookTwitterEmail 24
1of24A woman disinfects the handrails of the main dock gangway on Alcatraz Island in San Francisco, Monday, March 15, 2021. The historic island prison was reopened to visitors Monday after being closed since December because of the coronavirus threat. Visitors were also able to tour the inside of the main cell house for the first time in a year.Eric Risberg/APShow MoreShow Less
2of24People wearing face masks to protect against the spread of the coronavirus visit at Yasukuni shrine in Tokyo, Monday, March 15, 2021.Koji Sasahara/APShow MoreShow Less
The Latest: Mexico s president knocks US over vaccines
The Associated Press
FacebookTwitterEmail 9
1of9A police officer patrols in the Chatelet area amidst the new coronavirus pandemic, in Paris, Saturday, March 13, 2021.Thibault Camus/APShow MoreShow Less
2of9FILE - In this Friday, Feb. 19, 2021, file photo, medical transporter Adrian Parrilla moves a patient into a COVID-19 unit at Mission Hospital in Mission Viejo, Calif. There are 3,250 people hospitalized statewide, a drop of more than 85% since peaking around 22,000 in early January, the state Department of Public Health reported Saturday, March 13, 2021.Jae C. Hong/APShow MoreShow Less
3of9
4of9People enjoy the mild weather at the Burning Bush Trails park in Mount Prospect, Ill., Saturday, March 13, 2021. Illinois Gov. J.B. Pritzker announced on Friday that all Illinois adults could be eligible for a coronavirus vaccine before May.Nam Y. Huh/APShow MoreShow Less
Initial public offerings scheduled to debut next week
March 12, 2021
FacebookTwitterEmail
NEW YORK (AP) The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of March 15
Duckhorn Portfolio (The) - 20 million shares, priced $14-$16, managed by JP Morgan/Credit Suisse. Proposed NYSE symbol NAPA. Business: Produces and distributes luxury wine in North America.
Gain Therapeutics - Bethesda, Md., 3.6 million shares, priced $10-$12, managed by BTIG/Oppenheimer & Co. Proposed Nasdaq symbol GANX. Business: Preclinical biotech developing small molecule therapies for lysosomal storage.
Jowell Global - Shanghai, China, 3.7 million shares, priced at $7, managed by Network 1 Financial Securities. Proposed Nasdaq symbol JWEL. Business: Operates an e-commerce platform for cosmetics and health products in China.